BlackRock’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,109
Closed -$95.6K 5345
2024
Q1
$95.6K Sell
19,109
-349
-2% -$1.75K ﹤0.01% 4679
2023
Q4
$131K Sell
19,458
-10,080
-34% -$67.9K ﹤0.01% 4669
2023
Q3
$270K Sell
29,538
-1,700
-5% -$15.6K ﹤0.01% 4524
2023
Q2
$660K Sell
31,238
-62,330
-67% -$1.32M ﹤0.01% 4323
2023
Q1
$2.52M Sell
93,568
-1,622
-2% -$43.6K ﹤0.01% 3863
2022
Q4
$3.37M Buy
95,190
+4,001
+4% +$142K ﹤0.01% 3832
2022
Q3
$20.6M Sell
91,189
-702
-0.8% -$159K ﹤0.01% 2966
2022
Q2
$17.4M Buy
91,891
+10,416
+13% +$1.97M ﹤0.01% 3092
2022
Q1
$20.3M Sell
81,475
-957
-1% -$238K ﹤0.01% 3098
2021
Q4
$12.8M Sell
82,432
-39
-0% -$6.07K ﹤0.01% 3461
2021
Q3
$16.5M Sell
82,471
-66
-0.1% -$13.2K ﹤0.01% 3358
2021
Q2
$21.1M Sell
82,537
-1,161
-1% -$297K ﹤0.01% 3208
2021
Q1
$22.2M Buy
83,698
+4,522
+6% +$1.2M ﹤0.01% 3078
2020
Q4
$29.2M Buy
79,176
+4,303
+6% +$1.59M ﹤0.01% 2750
2020
Q3
$18.3M Buy
74,873
+9,287
+14% +$2.27M ﹤0.01% 2837
2020
Q2
$18.9M Buy
65,586
+3,446
+6% +$992K ﹤0.01% 2777
2020
Q1
$12.7M Sell
62,140
-850
-1% -$173K ﹤0.01% 2822
2019
Q4
$28.2M Buy
62,990
+3,603
+6% +$1.61M ﹤0.01% 2660
2019
Q3
$18.3M Buy
59,387
+1,748
+3% +$538K ﹤0.01% 2837
2019
Q2
$18.3M Buy
57,639
+42,547
+282% +$13.5M ﹤0.01% 2859
2019
Q1
$6.33M Sell
15,092
-531
-3% -$223K ﹤0.01% 3300
2018
Q4
$4.76M Buy
15,623
+8,135
+109% +$2.48M ﹤0.01% 3384
2018
Q3
$2.7M Buy
7,488
+179
+2% +$64.4K ﹤0.01% 3621
2018
Q2
$2.68M Buy
7,309
+4,612
+171% +$1.69M ﹤0.01% 3594
2018
Q1
$797K Buy
2,697
+1,737
+181% +$513K ﹤0.01% 3891
2017
Q4
$402K Buy
960
+24
+3% +$10.1K ﹤0.01% 4029
2017
Q3
$310K Sell
936
-22
-2% -$7.29K ﹤0.01% 4076
2017
Q2
$226K Sell
958
-5,230
-85% -$1.23M ﹤0.01% 4164
2017
Q1
$2.13M Buy
6,188
+6,183
+123,660% +$2.12M ﹤0.01% 3596
2016
Q4
$2K Hold
5
﹤0.01% 3599
2016
Q3
$2K Hold
5
﹤0.01% 3565
2016
Q2
$3K Buy
+5
New +$3K ﹤0.01% 3569